An Act respecting pharmacare

Short title: Pharmacare Act Bill C-64 (44-1) Status: Royal assent received Type: House Government Bill Sponsor: Mark Holland, Minister of Health (Ajax) Latest stage: Royal assent Legislative

summary <div>A legislative

summary is currently being prepared for this bill by the Parliamentary Information, Education and Research Services of the Library of Parliament. Meanwhile, the following executive

summary is available.<br/><br/>On February 2024, the Minister of Health introduced Bill C-64,

An Act respecting pharmacare (Pharmacare Act), and it was given first reading. <br/><br/>Bill C-64 sets out the principles that the Minister of Health is to consider when working towards the implementation of national universal pharmacare and provides the Minister with the power to make payments, in certain circumstances, in relation to the coverage of certain prescription drugs and related products.

It also sets out certain powers and obligations of the Minister — including in relation to the preparation of a list to inform the development of a national formulary and in relation to the development of a national bulk purchasing strategy — and requires the Minister to publish a pan-Canadian strategy regarding the appropriate use of prescription drugs and related products.

Finally, it provides for the establishment of a committee of experts to make certain recommendations.</div> House of Commons — First reading: Completed (2024-02-29) House of Commons — Second reading: Completed (2024-05-07) House of Commons — Consideration in committee: Completed (2024-05-28) House of Commons — Report stage: Completed (2024-05-30) House of Commons — Third reading: Completed (2024-06-03) Senate — First reading: Completed (2024-06-04) Senate — Second reading: Completed (2024-06-18) Senate — Consideration in committee: Completed (2024-10-03) Senate — Third reading: Completed (2024-10-10) LEGISinfo: https://www.parl.ca/legisinfo/en/bill/44-1/c-64